Cargando…
Adjuvant Therapy for Esophageal Squamous Cell Carcinoma
Adjuvant therapy for completely resected esophageal squamous cell carcinoma is less commonly applied in clinical practice than neoadjuvant therapy, but it plays a substantial role in improving survival for esophageal cancer patients. This article presents a concise review of the evidence regarding a...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society for Thoracic and Cardiovascular Surgery
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409891/ https://www.ncbi.nlm.nih.gov/pubmed/32793447 http://dx.doi.org/10.5090/kjtcs.2020.53.4.168 |
| _version_ | 1783568146314035200 |
|---|---|
| author | Sun, Jong-Mu |
| author_facet | Sun, Jong-Mu |
| author_sort | Sun, Jong-Mu |
| collection | PubMed |
| description | Adjuvant therapy for completely resected esophageal squamous cell carcinoma is less commonly applied in clinical practice than neoadjuvant therapy, but it plays a substantial role in improving survival for esophageal cancer patients. This article presents a concise review of the evidence regarding adjuvant therapy for esophageal squamous cell carcinoma and future directions, particularly immunotherapy. |
| format | Online Article Text |
| id | pubmed-7409891 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | The Korean Society for Thoracic and Cardiovascular Surgery |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74098912020-08-12 Adjuvant Therapy for Esophageal Squamous Cell Carcinoma Sun, Jong-Mu Korean J Thorac Cardiovasc Surg Collective of current Review, Lecture Adjuvant therapy for completely resected esophageal squamous cell carcinoma is less commonly applied in clinical practice than neoadjuvant therapy, but it plays a substantial role in improving survival for esophageal cancer patients. This article presents a concise review of the evidence regarding adjuvant therapy for esophageal squamous cell carcinoma and future directions, particularly immunotherapy. The Korean Society for Thoracic and Cardiovascular Surgery 2020-08-05 2020-08-05 /pmc/articles/PMC7409891/ /pubmed/32793447 http://dx.doi.org/10.5090/kjtcs.2020.53.4.168 Text en Copyright © The Korean Society for Thoracic and Cardiovascular Surgery. 2020. All right reserved. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Collective of current Review, Lecture Sun, Jong-Mu Adjuvant Therapy for Esophageal Squamous Cell Carcinoma |
| title | Adjuvant Therapy for Esophageal Squamous Cell Carcinoma |
| title_full | Adjuvant Therapy for Esophageal Squamous Cell Carcinoma |
| title_fullStr | Adjuvant Therapy for Esophageal Squamous Cell Carcinoma |
| title_full_unstemmed | Adjuvant Therapy for Esophageal Squamous Cell Carcinoma |
| title_short | Adjuvant Therapy for Esophageal Squamous Cell Carcinoma |
| title_sort | adjuvant therapy for esophageal squamous cell carcinoma |
| topic | Collective of current Review, Lecture |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409891/ https://www.ncbi.nlm.nih.gov/pubmed/32793447 http://dx.doi.org/10.5090/kjtcs.2020.53.4.168 |
| work_keys_str_mv | AT sunjongmu adjuvanttherapyforesophagealsquamouscellcarcinoma |